Immunotherapy Clinical Trials: Sue Scott’s Story of Survival
What is immunotherapy? Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control, and eliminate cancer. The focus of immunology research is to develop more effective ways to stimulate innate and adaptive immune responses to human tumors and to translate the most promising novel immunotherapies to cancer patients on clinical trials.
In October of 2011 Sue Scott was diagnosed with Stage 1B2 Cervical Cancer and completed what appeared to be successful treatment. Within 3 months there was evidence of active cancer cells, and her doctors told her that an Immunotherapy Clinical Trial was her only treatment option. See her success story here.